BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2011
View Archived Issues
Ibuprofen derivative mitigates effects of murine muscular dystrophy
Read More
New phosphodiesterase 3/4 inhibitor shows anti-inflammatory and bronchodilatory effects
Read More
Abbott reviews business highlights of third quarter 2011
Read More
Genfit's GFT-505 increases sensitivity to insulin in target organs
Read More
Cytonet expands SELICA III study to Canada
Read More
Study suggests montelukast improves pediatric atopic dermatitis
Read More
Pazopanib activity reported in soft tissue sarcoma and urothelial cancer
Read More
Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma
Read More
Korean research team presents novel angiogenesis inducers
Read More
New antisense oligonucleotides synthesized at Mirrx Therapeutics
Read More
Matrix Pharma claims novel thrombin inhibitors
Read More
Okayama University discloses new COX-1 inhibitors
Read More
Novel antivirals prepared at Vertex
Read More
Halozyme reports phase II data on ultrafast insulin analogue formulations
Read More
AMAG Pharmaceuticals terminates merger agreement
Read More
Dynavax and GSK add new target in Toll-like receptor inhibitor program
Read More
Intercell reports first-in-human data on Clostridium difficile vaccine
Read More
FDA to review linaclotide NDA
Read More
Daiichi Sankyo and AstraZeneca seek approval for new Nexium indication in Japan
Read More
CHMP clarifies opinion on pioglitazone and the risk of bladder cancer
Read More
Progenra and Tokyo Medical University begin rheumatoid arthritis collaboration
Read More
FDA issues update on drug interactions with linezolid
Read More
Silence Therapeutics and Mirna Therapeutics enter microRNA collaboration
Read More
First-in-human AVI-6003 trial advances
Read More
FDA approves label update for Prezista
Read More